Thus multimodal therapy with VEGF-A pathway inhibition, HIF-1α inhibition, and hypoxia-activated chemotherapy effectively blocks sarcoma growth though induction of apoptosis, loss of tumor vasculature, and inhibition of HIF-1α. This evidence concerns the gene VEGFA and sarcoma.